Updated Jul 16, 2026
Shepard Jay has filed 4 SEC Form 4 filings across 3 companies in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-13 | ESPR | Esperion Therapeutics, Inc. | D — Derivative transaction | 164.5K | — | |
| 2026-06-17 | IRWD | IRONWOOD PHARMACEUTICALS INC | A — Grant or award | 63.5K | $0.00 | |
| 2026-06-01 | ESPR | Esperion Therapeutics, Inc. | A — Grant or award | 79.9K | $0.00 | |
| 2025-05-21 | INO | INOVIO PHARMACEUTICALS, INC. | M — Option exercise | 2.2K | — |
Shepard Jay is a corporate insider — currently tracked as Director of Esperion Therapeutics, Inc. (ESPR). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 3 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Shepard Jay profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.